| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |